个性化医学:ALK阳性非小细胞肺癌的范式转变:一个病例报告
João Vasco Barreira1,2, José Leão Mendes3, Anuraj Parmanande4
1CUF Oncologia, Lisboa, Portugal. joaovascobarreira@gmail.com.
Journal of medical case reports
|September 1, 2023
概括
新的形淋巴瘤激酶 (ALK) 向疗法为非小细胞肺癌 (NSCLC) 患者提供了改善的治疗结果. 这些治疗方法使患者能够保持日常生活,同时有效地管理他们的病情.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 无细胞淋巴瘤激酶 (ALK) 转位代表非小细胞肺癌 (NSCLC) 的关键治疗标.
- 在识别生物标志物和向治疗方面的进展改善了NSCLC患者的治疗模式.
研究的目的:
- 为了说明ALK阳性非小细胞肺癌患者的临床旅程.
- 在现实世界中突出突出针对ALK的新型疗法的疗效和耐受性.
主要方法:
- 一个临床案例研究的介绍,涉及一个不吸烟的中年男性患者.
- 专注于患者对形淋巴瘤激酶 (ALK) 向治疗的经验.
主要成果:
- 该案例证明了针对ALK的新疗法在治疗非小细胞肺癌方面的有效性.
- 疗法被证明是可以容忍的,使患者能够维持日常活动,而不会影响治疗的有效性.
结论:
- 针对ALK的疗法对ALK阳性非小细胞肺癌患者的日常生活产生积极影响.
- 提高对ALK阳性非小细胞肺癌和向治疗的好处的认识至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


